Tvardi Therapeutics, Inc. (TVRD) earnings
TVRD earnings moved a median of +0.04% by the close. Quarterly and annual TVRD reports and results, each read against the price at its own news timestamp. Back to the TVRD overview →
10 measured TVRD earnings events.
Where these TVRD earnings landedvs 10 measured TVRD earnings reactions
| Middle 50% of TVRD earnings reactions | -2.21% to +3.33% |
|---|---|
| Median reaction (to close) | +0.04% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 TVRD earnings events with a measured close landed between -2.21% and +3.33%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Tvardi Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -4.31% | +1.72% | |
| Tvardi Therapeutics Announces Third Quarter 2026 Results and Provides Business Update | Press release | -4.31% | +1.72% | |
| Form 10-Q Tvardi Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +4.97% | +4.97% | |
| Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update | Press release | +4.97% | +4.97% | |
| Form 10-Q Tvardi Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.06% | -1.65% | |
| Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update | Press release | -3.06% | -1.65% | |
| Form 10-K Tvardi Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -3.45% | -4.15% | |
| Form 10-Q Tvardi Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.40% | |
| Tvardi Therapeutics Announces Second Quarter 2025 Results and Provides Business Update | Press release | +0.00% | -2.40% | |
| Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update | Press release | +0.00% | +3.86% |
Keep exploring
More TVRD: analyst actions → · SEC filings → · TVRD overview →